Étude de phase II « basket » évaluant l’efficacité de l’anticorps monoclonal bispécifique anti-HER2/HER3 MCLA-128 chez les patients atteints de tumeurs solides avancées présentant un réarrangement NRG1
Year: 2020
Type: article
Authors: A.M. Schram, A. Drilon, T. Macarulla, E.M. O’ Reilly, J. Rodon, B. Wolpin, S.H. Ou, D.W. Kim, J.C. Yang, J. Lam Yick Ching, A. Varga, A.J. De Langen, P. Witteveen, V. Boni, G. Cerea, M. Duruisseaux, S. Liu, E. Wasserman, D.M. Hyman, J. Tabernero
Institutions: Memorial Sloan Kettering Cancer Center, Vall d'Hebron Hospital Universitari, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, University of California, Irvine, Seoul National University Hospital, National Taiwan University Hospital, Institut Gustave Roussy, The Netherlands Cancer Institute, University Medical Center Utrecht, Hospital Universitario HM Sanchinarro, University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Hospices Civils de Lyon, Georgetown University, Georgetown University Medical Center, Merus (Netherlands)
Language: French
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2996923327